Natrol (NASDAQ:NTOL)
Historical Stock Chart
From Jun 2019 to Jun 2024
Natrol, Inc. (Nasdaq:NTOL), a leading manufacturer and marketer of
nationally branded nutritional products, today announced operating
results for the period ended June 30, 2007.
Sales during the quarter rose 17.8% to $19.5 million compared to $16.6
million in the year-ago quarter. The Company attributed the sales
increase to a strong performance from new products which more than
offset a $0.9 million decline that results from the planned
discontinuation of Ester-C. At the same time, the Company saw
significant improvement in gross margin, which rose 410 basis points to
47.5% versus 43.4% in the year-ago quarter. The Company noted that while
core expenses showed leverage as costs were controlled, it also invested
in building platforms for growth in both the United Kingdom and in the
Far East. Even with this investment spending, the company saw a sharp
increase in operating income, which rose 172.9% to $737,000 versus
$270,000 in the second quarter of 2006.
Earnings per share for the second quarter were $0.25 per diluted share
versus $0.01 per diluted share in the year-ago quarter. The Company
noted that during the quarter, it booked a $6.1 million one-time gain on
the sale of its corporate facilities which had the effect of increasing
reported earnings by $0.22 per share.
Wayne Bos, President and CEO of Natrol, commented, “We
are very pleased by the progress we made this past quarter. In addition
to good financial results, we made excellent strategic progress with our
business. The acquisition of MRI closed late in the quarter and further
diversified our business. MRI provides not only a premium brand but
contributes a strong, science-based pipeline for further penetration and
market development of higher-growth areas of the nutraceutical business.
The sale and lease back transaction we completed has given us ready
access to capital and the ability to continue to enter into strategic
transactions to leverage the considerable platform we are building with
a balance sheet that is essentially debt free.”
Mr. Bos concluded, “We are confident of our
solid and sustainable turnaround in the business of Natrol. Our brand
portfolio, which targets several important tiers of distribution, is
reliable and growing. We are positioned well to enter the international
marketplace. The enhancement of our strategic vision by MRI positions
Natrol to again be a company with genuine growth. We believe that we are
well positioned to continue our growth trajectory and drive significant
value to our shareholders.”
Natrol, Inc. and Subsidiaries
Consolidated Condensed Balance Sheets
(In thousands, except share and per share data)
June 30
December 31
2007
2006
(unaudited)
Assets
Current assets:
Cash and cash equivalents
$
8,640
$
1,003
Accounts receivable, net of allowances of $241 and $181 at June 30,
2007 and December 31, 2006, respectively
11,274
6,485
Inventory
20,057
11,788
Income taxes receivable
—
375
Deferred income taxes
1,635
1,630
Prepaid expenses and other current assets
1,164
1,743
Total current assets
42,770
23,024
Property and equipment:
Building and improvements
—
14,953
Machinery and equipment
6,122
5,757
Furniture and office equipment
3,038
3,013
9,160
23,723
Accumulated depreciation and amortization
(7,343
)
(9,912
)
Property and equipment, net
1,817
13,811
Restricted cash
5,250
5,000
Deferred income taxes
4,265
4,265
Goodwill, net of accumulated amortization and impairment charge
2,026
2,026
Trademarks
5,730
5,730
Other assets
1,047
744
Total assets
$
62,905
$
54,600
Liabilities and stockholders’ equity
Current liabilities:
Line of credit
$
—
$
3,694
Accounts payable
8,039
3,058
Accrued expenses
3,081
2,558
Accrued payroll and related liabilities
1,364
1,185
Income taxes payable
2,850
—
Current portion of long-term debt
12
414
Total current liabilities
15,346
10,909
Long-term debt, less current portion
31
6,301
Deferred benefit from sale leaseback
5,280
—
Commitments and contingencies
—
—
Stockholders’ equity:
Preferred stock, par value of $0.01 per share:Authorized shares—2,000,000;
Issued and outstanding shares—none
—
—
Common stock, par value of $0.01 per share:Authorized shares—50,000,000,
Issued and outstanding shares—14,155,544
and 14,116,148 at June 30, 2007 and December 31, 2006, respectively
142
141
Additional paid-in capital
61,965
61,638
Accumulated deficit
(19,896
)
(24,409
)
Accumulated other comprehensive income
37
20
Total stockholders’ equity
42,248
37,390
Total liabilities and stockholders’ equity
$
62,905
$
54,600
Natrol, Inc. and Subsidiaries
Consolidated Condensed Statements of Income
(In thousands, except share and per share data)
(unaudited)
Three months ended
Six months ended
June 30,
June 30,
2007
2006
2007
2006
Net sales
$
19,547
$
16,587
$
38,254
$
33,511
Cost of goods sold
10,263
9,394
20,184
19,423
Gross profit
9,284
7,193
18,070
14,088
Selling and marketing expenses
5,549
4,092
10,575
8,183
General and administrative expenses
2,998
2,831
6,015
5,649
Total operating expenses
8,547
6,923
16,590
13,832
Operating income
737
270
1,480
256
Interest income
151
60
184
116
Interest expense
(70)
(153)
(291)
(307)
Other (Loss)
(35)
—
(35)
—
Gain on sale of property
6,062
—
6,062
230
Income before taxes
6,845
177
7,400
295
Income tax provision
2,672
77
2,887
122
Net income
$
4,173
$
100
$
4,513
$
173
Income per share:
Basic
$
0.29
$
0.01
$
0.32
$
0.01
Diluted
$
0.25
$
0.01
$
0.28
$
0.01
Weighted-average shares outstanding—basic
and diluted
Basic
14,153,601
13,563,747
14,149,355
13,557,115
Diluted
16,763,440
13,914,763
16,093,514
13,865,531
About Natrol – Nourishing the Potential
of Mind and Body SM
Natrol, Inc. (Nasdaq: NTOL), headquartered in Chatsworth, CA, has a
portfolio of health and wellness brands representing quality nutritional
supplements, functional herbal teas, and sports nutrition products.
Established in 1980, Natrol’s portfolio of
brands includes: Natrol®,
Prolab®, Laci Le Beau®,
Promensil®, Trinovin®,
Nu Hair®,Shen Min®
,and MRI®. The
company also manufactures supplements for its own brands and on behalf
of third parties.
Natrol distributes products nationally through more than 54,000
retailers, as well as internationally in over 40 other countries through
distribution partners and subsidiaries in the UK and Hong Kong. For more
information, visit www.Natrol.com.
The statements made in this press release which are not historical
facts, including statements regarding expectations for future growth of
revenue and profits and trends concerning net sales, are forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. As a result
of a number of factors, our actual results could differ materially from
those set forth in the forward-looking statements. Certain factors that
might cause our actual results to differ materially from those in the
forward-looking statements include, without limitation: (i) our ability
to develop and execute our business plans, (ii) our ability to respond
to competitive challenges and changing consumer preferences, (iii) our
ability to consummate and integrate acquisitions, (iv) increased
competition, (v) unfavorable publicity about dietary supplements in
general or regarding our products or similar products sold by others,
(vi) our exposure to product liability claims, our dependence upon
certain large customers, and (vii) our ability to retain and attract
talented management and other key employees, as well as those factors
set forth under the heading "Risk Factors" in our annual report on Form
10-K for the year ended December 31, 2006, and in our other filings with
the Securities and Exchange Commission.